A 68-year-old Indian man presents with progressive weakness and fatigue over 3 months. He reports difficulty climbing stairs and lifting objects. On examination, his strength improves after brief rest and worsens with sustained activity. Serology is positive for anti-acetylcholine receptor (AChR) antibodies. Repetitive nerve stimulation shows a decremental response. Which of the following best explains the pathophysiology of his neuromuscular junction dysfunction?

Explanation

## Diagnosis: Myasthenia Gravis (MG) **Key Point:** Myasthenia gravis is an autoimmune disorder targeting the neuromuscular junction, characterized by antibodies against acetylcholine receptors (AChR) in ~85% of generalized cases. ## Pathophysiology of AChR Antibody-Mediated MG ### Mechanism of Neuromuscular Dysfunction 1. **Antibody Binding and Complement Activation** - IgG antibodies bind to AChR on the postsynaptic membrane - Classical complement pathway is activated (C1q → C3 → MAC) - Membrane attack complex (MAC) creates pores in the postsynaptic membrane 2. **Structural Consequences** - Destruction of the postsynaptic membrane and junctional folds - Loss of acetylcholine receptors (cross-linking and internalization) - Widening of the synaptic cleft - Flattening of the postsynaptic membrane architecture 3. **Functional Consequence: Reduced Safety Margin** - Normal safety margin = 4–5× (EPP amplitude >> threshold for AP generation) - In MG: reduced number of functional AChR → smaller EPP - EPP may fall below threshold, especially with repeated stimulation - Result: **Failure of neuromuscular transmission** with activity ### Clinical Correlation: Decremental Response **High-Yield:** Repetitive nerve stimulation (RNS) shows a **decremental response** (>10% drop in CMAP amplitude) because: - Each action potential releases a fixed quantum of acetylcholine - With fewer receptors, the EPP amplitude progressively falls - By the 3rd–5th stimulus, EPP drops below threshold - Muscle action potential fails → CMAP amplitude decreases ### Why Symptoms Improve with Rest - Acetylcholine is continuously synthesized and stored - Rest allows EPP amplitude to recover toward baseline - Explains the **fatigability** (worsens with use, improves with rest) hallmark of MG ```mermaid flowchart TD A[Anti-AChR Antibodies]:::outcome --> B[Complement Activation<br/>C1q → C3 → MAC]:::action B --> C[Postsynaptic Membrane<br/>Destruction]:::action C --> D[Loss of AChR<br/>Widened Synaptic Cleft]:::outcome D --> E[Reduced EPP Amplitude]:::outcome E --> F{EPP vs Threshold}:::decision F -->|EPP > Threshold| G[Action Potential Generated]:::action F -->|EPP < Threshold| H[Neuromuscular Transmission Failure]:::urgent H --> I[Muscle Weakness &<br/>Fatigability]:::outcome ``` **Clinical Pearl:** The **safety margin** concept is central: even though each quantum of ACh is released normally, the reduced number of receptors means fewer ions flow inward, and the EPP amplitude falls below the threshold needed to trigger an action potential. **Mnemonic: SAFE MARGIN** — **S**mall EPP, **A**ChR antibodies, **F**atigability, **E**ventual failure; **M**embrane attack complex, **A**utoimmune, **R**eceptor loss, **G**radual decline, **I**ncremental improvement with rest, **N**euromuscular junction.